Skip to content

An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications: The PRIME-AIR Study

An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications: The PRIME-AIR Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04108130
Acronym
PRIME-AIR
Enrollment
794
Registered
2019-09-27
Start date
2020-01-29
Completion date
2023-07-13
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pulmonary Complications

Brief summary

Postoperative pulmonary complications (PPCs) are a major cause of morbidity and mortality in surgical patients. National estimates suggest 1,062,000 PPCs per year, with 46,200 deaths, and 4.8 million additional days of hospitalization. The objective of the study is to develop and implement perioperative strategies to eliminate PPCs in abdominal surgery, the field with the largest absolute number of PPCs. We will conduct a randomized controlled pragmatic trial in 750 studied participants. The effectiveness of an individualized perioperative anesthesia-centered bundle will be compared to the usual anesthetic care in patients receiving open abdominal surgery. At the end of this project, the investigators expect to change clinical practice by establishing a new and clinically feasible anesthesia-centered strategy to reduce perioperative lung morbidity. The research will be conducted across 14 US academic centers, and will be funded by the National Institute of Health.

Detailed description

Postoperative pulmonary complications (PPCs) are a major cause of morbidity and mortality in surgical patients. National estimates suggest 1,062,000 PPCs per year, with 46,200 deaths, and 4.8 million additional days of hospitalization. Abdominal surgery is the field with the largest absolute number of PPCs. The long-term goal is to develop and implement perioperative strategies to eliminate PPCs. Whereas PPCs are as significant and lethal as cardiac complications, research in the field has received much less attention, and strategies to minimize PPCs are regrettably limited. Recently, the investigators and others have suggested a crucial role of anesthesia related interventions such as ventilatory strategies, and administration and reversal of neuromuscular blocking agents in reducing PPCs. These findings are consistent with the beneficial effects of lung protective ventilation during the adult respiratory distress syndrome (ARDS). While surgical patients differ substantially from ARDS patients as most have no or limited lung injury at the start of surgery, intraoperative anesthetic and abdominal surgery interventions result in lung derecruitment and predispose to or produce direct and indirect, potentially multiple-hit, lung injury. Thus, effective anesthetic strategies aiming at early lung protection in this group of patients are greatly needed. Indeed, the current lack of evidence results in wide and unexplained variability in anesthetic practices creating a major public health issue as some practices within usual care appear to be suboptimal and even potentially injurious. The investigators hypothesize that an anesthesia-centered bundle, based on recent findings and focused on perioperative lung protection, will minimize multiple and synergistic factors responsible for the multiple-hit perioperative pulmonary dysfunction and result in decreased incidence and severity of PPCs. Founded on strong preliminary data, we will leverage a network of US academic centers to study this hypothesis in two aims: Aim 1. To compare the number and severity of PPCs in participants receiving an individualized perioperative anesthesia-centered bundle to those in participants receiving usual anesthetic care during open abdominal surgery. For this, the investigators propose to conduct a prospective multicenter randomized controlled pragmatic trial with a blinded assessor in a total of 750 studied participants. The bundle will consist of optimal mechanical ventilation comprising individualized positive end-expiratory pressure to maximize respiratory system compliance and minimize driving pressures, individualized use of neuromuscular blocking agents and their reversal, and postoperative lung expansion and early mobilization; Aim 2. To assess the effect of the proposed bundle on plasma levels of lung injury biomarkers. The investigators theorize that our intervention will minimize overinflation and atelectasis reducing plasma levels of biomarkers of lung inflammatory, epithelial, and endothelial injury. Such mechanistic insights will facilitate bundle dissemination and support adoption as it has for lung protective ventilation for ARDS. At the end of this project, the investigators expect to change clinical practice by establishing a new and clinically feasible anesthesia-centered strategy to reduce perioperative lung morbidity.

Interventions

Brochure and video about relevance of postoperative pulmonary complications, postoperative mobilization and use of incentive spirometry.

PROCEDUREIntraoperative PEEP (Positive End-Expiratory Pressure) Individualization

PEEP will be set by maximizing respiratory system compliance along a decremental PEEP titration following an incremental recruitment maneuver.

OTHERIndividualization of Neuromuscular Blockade

Administration of neuromuscular blocking agents and their reversal will be done based on established protocol.

PROCEDUREPostoperative Incentive Spirometry

Participants will be encouraged to adhere to incentive spirometry to be started 2 hours after surgery and maintained until participant freely ambulates. Supervision will be provided 3 times/day for continuous education and management of barriers to optimal performance.

BEHAVIORALPostoperative Ambulation

Participants will be encouraged to adhere to prescription of early ambulation.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (\>=18 years) scheduled for elective surgery with expected duration \>=2 hours * Open abdominal surgery including: gastric, biliary, pancreatic, hepatic, major bowel, ovarian, renal tract, bladder, prostatic, radical hysterectomy, and pelvic exenteration * Intermediate or high risk of PPCs defined by an ARISCAT (Assess Respiratory Risk in Surgical Patients in Catalonia Score) risk score\>=26

Exclusion criteria

* Inability or refusal to provide consent * Inability or significant difficulty to perform any study interventions, including incentive spirometry, ambulation and/or maintaining follow-up contact with study personnel for up to 90 days after the date of surgery. * Participation in any interventional research study within 30 days of the time of the study. * Previous surgery within 30 days prior to this study. * Pregnancy * Emergency surgery * Severe obesity (above Class I, BMI\>=35 kg/m2) * Significant lung disease: any diagnosed or treated respiratory condition that (a) requires home oxygen therapy or non-invasive ventilation (except nocturnal treatment of sleep apnea without supplemental oxygen), (b) severely limits exercise tolerance to \<4 metabolic equivalents (METs) (e.g., patients unable to do light housework, walk flat at 4 miles/h or climb one flight of stairs), (c) required previous lung surgery, or (d) includes presence of severe pulmonary emphysema or bullae * Significant heart disease: cardiac conditions that limit exercise tolerance to \<4 METs * Renal failure: peritoneal or hemodialysis requirement or preoperative creatinine \>=2 mg/dL * Neuromuscular disease that impairs ability to ventilate without assistance * Severe chronic liver disease (Child-Turcotte-Pugh Score \>9, Appendix I) * Sepsis * Malignancy or other irreversible condition for which 6-month mortality is estimated \>=20% * Bone marrow transplant

Design outcomes

Primary

MeasureTime frameDescription
Number and Severity of Postoperative Pulmonary Complications Between Participant GroupsPostoperative Days 0 through 7The distribution of the number and severity of accumulated post-operative pulmonary complications (PPCs) between the control and intervention groups during the first 7 days after surgery.

Secondary

MeasureTime frameDescription
Number of Participants With Grade 3 and 4 Postoperative Pulmonary ComplicationsPostoperative Days 7, 30, and 90Individual grade 3 and 4 postoperative pulmonary complications within 7, 30, and 90 days after the day of the surgery.
Number of Participants With Hypoxemia by Postoperative Day 7Postoperative Days 0 through 7Presence of any hypoxemia (as defined in PPC grade 1 and 2) within 7 days after the day of the surgery.
Number of Participants With Atelectasis by Postoperative Day 7Days 0 through 7 after the day of surgeryPresence of atelectasis (radiological confirmation + either temperature \>37.5°C or abnormal lung symptoms/signs) by day 7 after the date of surgery.
Number of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 7Days 0 through 7Incidence of suspected (radiological evidence without bacteriological confirmation) and proved (radiological evidence and documentation of pathological organism) pneumonia by day 7 after the date of surgery.
Number of Participants With Ventilatory Dependence or Failure by Postoperative Day 7Days 0 through 7Number of participants with ventilatory dependence (Grade 3, non-invasive or invasive ventilation \< 48h) or failure (Grade 4, postoperative non-invasive or invasive ventilation dependence ≥ 48h) by day 7 after the date of surgery.
Number of Participants With Grade 1 and 2 Postoperative Pulmonary ComplicationsPostoperative Days 0 through 7Individual grade 3 and 4 postoperative pulmonary complications within 7 days after the day of the surgery.
Number of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment ManeuversDay 0The incidence of both intraoperative hypoxemia (SpO2 \< 85%) and rescue recruitment maneuvers during surgery. Received unplanned RM or PEEP titrations or adjustments during surgery for oxygenation or ventilation rescue.
Number of Participants With Intraoperative Cardiovascular EventsDay 0Number of participants with hypotension, bradycardia, tachycardia, arrhythmias, new ST-segment changes and cardiac arrest
Length of Hospital StayDays 0 through 7, 30, and 90Number of days the participant has spent in the hospital since the day of the surgery.
Number of Participants With Other Hospital Readmission(s) After Initial DischargeAfter the date of discharge to day 90The number of participants with hospital readmission(s), other than to the Intensive Care Unit, if admitted.
Number of Participants With Any Major Extrapulmonary ComplicationsDays 0 to 7Number of participants with arrhythmia, paralytic ileus, surgical site infection, infection (source uncertain), acute renal failure, and systemic inflammatory response syndrome.
Length of Postoperative Oxygen SupportUp to 7 days post-surgeryNumber of time (hours or days) spent in the postoperative oxygen therapy or other respiratory support

Countries

United States

Participant flow

Participants by arm

ArmCount
Usual Care
Participants in this arm will receive usual anesthetic and postoperative care as provided in each site.
372
Intervention
This arm will receive the bundle of perioperative interventions.
379
Total751

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyConsent Not Obtained for Other Reasons33
Overall StudyConsent Withdrawn96
Overall StudyFound Ineligible for Study43
Overall StudyIntervention Not Done and No Data Collected01
Overall StudySurgery Cancelled44
Overall StudyVerbal Agreement Withdrawn42

Baseline characteristics

CharacteristicUsual CareInterventionTotal
Age, Continuous62.4 years
STANDARD_DEVIATION 12
61.1 years
STANDARD_DEVIATION 13.5
61.7 years
STANDARD_DEVIATION 12.8
ARISCAT Total Score40.9 score on a scale
STANDARD_DEVIATION 7.6
41.0 score on a scale
STANDARD_DEVIATION 7.2
41.0 score on a scale
STANDARD_DEVIATION 7.4
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
21 Participants14 Participants35 Participants
Race (NIH/OMB)
Black or African American
23 Participants21 Participants44 Participants
Race (NIH/OMB)
More than one race
7 Participants3 Participants10 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
43 Participants47 Participants90 Participants
Race (NIH/OMB)
White
278 Participants294 Participants572 Participants
Sex: Female, Male
Female
190 Participants170 Participants360 Participants
Sex: Female, Male
Male
182 Participants209 Participants391 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
5 / 3966 / 398
other
Total, other adverse events
19 / 39636 / 398
serious
Total, serious adverse events
35 / 39635 / 398

Outcome results

Primary

Number and Severity of Postoperative Pulmonary Complications Between Participant Groups

The distribution of the number and severity of accumulated post-operative pulmonary complications (PPCs) between the control and intervention groups during the first 7 days after surgery.

Time frame: Postoperative Days 0 through 7

Population: Individual PPCs experienced by participants in both study arms.

ArmMeasureGroupValue (NUMBER)
Usual CareNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGrade 1 (mild)35 complications
Usual CareNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGrade 3 (severe)27 complications
Usual CareNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGrade 2 (moderate)225 complications
Usual CareNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGade 4 (ventilatory failure)1 complications
Usual CareNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGrade 0 (none)84 complications
InterventionNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGade 4 (ventilatory failure)3 complications
InterventionNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGrade 0 (none)73 complications
InterventionNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGrade 1 (mild)51 complications
InterventionNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGrade 2 (moderate)211 complications
InterventionNumber and Severity of Postoperative Pulmonary Complications Between Participant GroupsGrade 3 (severe)41 complications
Secondary

Length of Hospital Stay

Number of days the participant has spent in the hospital since the day of the surgery.

Time frame: Days 0 through 7, 30, and 90

ArmMeasureValue (MEAN)Dispersion
Usual CareLength of Hospital Stay6.8 daysStandard Deviation 5.9
InterventionLength of Hospital Stay7.2 daysStandard Deviation 6.1
Secondary

Length of Postoperative Oxygen Support

Number of time (hours or days) spent in the postoperative oxygen therapy or other respiratory support

Time frame: Up to 7 days post-surgery

ArmMeasureValue (MEDIAN)
Usual CareLength of Postoperative Oxygen Support19.2 hours
InterventionLength of Postoperative Oxygen Support14.6 hours
Secondary

Number of Participants With Any Major Extrapulmonary Complications

Number of participants with arrhythmia, paralytic ileus, surgical site infection, infection (source uncertain), acute renal failure, and systemic inflammatory response syndrome.

Time frame: Days 0 to 7

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Any Major Extrapulmonary Complications43 Participants
InterventionNumber of Participants With Any Major Extrapulmonary Complications48 Participants
Secondary

Number of Participants With Atelectasis by Postoperative Day 7

Presence of atelectasis (radiological confirmation + either temperature \>37.5°C or abnormal lung symptoms/signs) by day 7 after the date of surgery.

Time frame: Days 0 through 7 after the day of surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Atelectasis by Postoperative Day 759 Participants
InterventionNumber of Participants With Atelectasis by Postoperative Day 770 Participants
Secondary

Number of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment Maneuvers

The incidence of both intraoperative hypoxemia (SpO2 \< 85%) and rescue recruitment maneuvers during surgery. Received unplanned RM or PEEP titrations or adjustments during surgery for oxygenation or ventilation rescue.

Time frame: Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment Maneuvers21 Participants
InterventionNumber of Participants With Both Intraoperative Hypoxemia and Rescue Recruitment Maneuvers6 Participants
Secondary

Number of Participants With Grade 1 and 2 Postoperative Pulmonary Complications

Individual grade 3 and 4 postoperative pulmonary complications within 7 days after the day of the surgery.

Time frame: Postoperative Days 0 through 7

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Grade 1 and 2 Postoperative Pulmonary Complications260 Participants
InterventionNumber of Participants With Grade 1 and 2 Postoperative Pulmonary Complications262 Participants
Secondary

Number of Participants With Grade 3 and 4 Postoperative Pulmonary Complications

Individual grade 3 and 4 postoperative pulmonary complications within 7, 30, and 90 days after the day of the surgery.

Time frame: Postoperative Days 7, 30, and 90

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Grade 3 and 4 Postoperative Pulmonary ComplicationsMost Severe PPC Grade 3 or 4 by POD 728 Participants
Usual CareNumber of Participants With Grade 3 and 4 Postoperative Pulmonary ComplicationsMost Severe PPC Grade 3 or 4 by POD 3032 Participants
Usual CareNumber of Participants With Grade 3 and 4 Postoperative Pulmonary ComplicationsMost Severe PPC Grade 3 or 4 by POD 9035 Participants
InterventionNumber of Participants With Grade 3 and 4 Postoperative Pulmonary ComplicationsMost Severe PPC Grade 3 or 4 by POD 744 Participants
InterventionNumber of Participants With Grade 3 and 4 Postoperative Pulmonary ComplicationsMost Severe PPC Grade 3 or 4 by POD 3049 Participants
InterventionNumber of Participants With Grade 3 and 4 Postoperative Pulmonary ComplicationsMost Severe PPC Grade 3 or 4 by POD 9053 Participants
Secondary

Number of Participants With Hypoxemia by Postoperative Day 7

Presence of any hypoxemia (as defined in PPC grade 1 and 2) within 7 days after the day of the surgery.

Time frame: Postoperative Days 0 through 7

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Hypoxemia by Postoperative Day 7263 Participants
InterventionNumber of Participants With Hypoxemia by Postoperative Day 7284 Participants
Secondary

Number of Participants With Intraoperative Cardiovascular Events

Number of participants with hypotension, bradycardia, tachycardia, arrhythmias, new ST-segment changes and cardiac arrest

Time frame: Day 0

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Intraoperative Cardiovascular Events18 Participants
InterventionNumber of Participants With Intraoperative Cardiovascular Events21 Participants
Secondary

Number of Participants With Other Hospital Readmission(s) After Initial Discharge

The number of participants with hospital readmission(s), other than to the Intensive Care Unit, if admitted.

Time frame: After the date of discharge to day 90

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Other Hospital Readmission(s) After Initial Discharge0 Participants
InterventionNumber of Participants With Other Hospital Readmission(s) After Initial Discharge0 Participants
Secondary

Number of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 7

Incidence of suspected (radiological evidence without bacteriological confirmation) and proved (radiological evidence and documentation of pathological organism) pneumonia by day 7 after the date of surgery.

Time frame: Days 0 through 7

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 718 Participants
InterventionNumber of Participants With Pneumonia (Suspected and Proved) by Postoperative Day 728 Participants
Secondary

Number of Participants With Ventilatory Dependence or Failure by Postoperative Day 7

Number of participants with ventilatory dependence (Grade 3, non-invasive or invasive ventilation \< 48h) or failure (Grade 4, postoperative non-invasive or invasive ventilation dependence ≥ 48h) by day 7 after the date of surgery.

Time frame: Days 0 through 7

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Participants With Ventilatory Dependence or Failure by Postoperative Day 715 Participants
InterventionNumber of Participants With Ventilatory Dependence or Failure by Postoperative Day 722 Participants

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026